ELDA: real-time functional drug profiling in acute lymphoblastic leukemia
{{output}}
Introduction: Pediatric acute lymphoblastic leukemia (ALL) has cure rates exceeding 80%, yet approximately 20% of patients experience relapse, for whom treatment remains challenging. The biological and clinical heterogeneity of A... ...